Source: Clinical Pharmacology & Therapeutics. Unidade: FMRP
Subjects: POLIMORFISMO, PRESSÃO SANGUÍNEA, RESISTÊNCIA VASCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRETORIUS, M. M. et al. The bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistance. Clinical Pharmacology & Therapeutics, v. 83, n. 1, p. 122-129, 2008Tradução . . Acesso em: 17 nov. 2024.APA
Pretorius, M. M., Gainer, J. V., Guilder, G. P. V., Coelho, E. B., Luther, J. M., Fong, P., et al. (2008). The bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistance. Clinical Pharmacology & Therapeutics, 83( 1), 122-129.NLM
Pretorius MM, Gainer JV, Guilder GPV, Coelho EB, Luther JM, Fong P, Rosenbaum DD, Malave HA, Yu C, Ritchie MD, Vaughan DE, Brown NJ. The bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistance. Clinical Pharmacology & Therapeutics. 2008 ; 83( 1): 122-129.[citado 2024 nov. 17 ]Vancouver
Pretorius MM, Gainer JV, Guilder GPV, Coelho EB, Luther JM, Fong P, Rosenbaum DD, Malave HA, Yu C, Ritchie MD, Vaughan DE, Brown NJ. The bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistance. Clinical Pharmacology & Therapeutics. 2008 ; 83( 1): 122-129.[citado 2024 nov. 17 ]
